A Tailored 7- to 10-Day Lenalidomide Desensitization Protocol

J Investig Allergol Clin Immunol. 2024 Feb 22;34(1):49-50. doi: 10.18176/jiaci.0914. Epub 2023 Jun 1.

Authors

K Pose¹, E Narváez-Fernández¹, A López de la Guía², L De Las Vecillas^{1

3}, J Domínguez-Ortega^{1

3

4}, M Lluch-Bernal^{1

3}, A Fiandor^{1

3}, R Cabañas^{1

3

5

6}

Affiliations

¹ Department of Allergy, La Paz University Hospital, Madrid, Spain.
² Department of Hematology, La Paz University Hospital, Madrid, Spain.
³ La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
⁴ CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
⁵ PIELenRed Consortium.
⁶ Centro de Investigación en Red de Enfermedades Raras (CIBERER, U754).

PMID: 37261938
DOI: 10.18176/jiaci.0914

No abstract available

Keywords: Desensitization protocol; Drug-induced hypersensitivity syndrome; Lenalidomide.

MeSH terms

Desensitization, Immunologic / methods
Drug Hypersensitivity* / diagnosis
Drug Hypersensitivity* / etiology
Drug Hypersensitivity* / therapy
Humans
Lenalidomide / adverse effects

Substances

Lenalidomide